EMAIL THIS PAGE TO A FRIEND

PloS one

Alternative inactivated poliovirus vaccines adjuvanted with Quillaja brasiliensis or Quil-a saponins are equally effective in inducing specific immune responses.


PMID 25148077

Abstract

Inactivated polio vaccines (IPV) have an important role at the final stages of poliomyelitis eradication programs, reducing the risks associated with the use of attenuated polio vaccine (OPV). An affordable option to enhance vaccine immunogenicity and reduce costs of IPV may be the use of an effective and renewable adjuvant. In the present study, the adjuvant activity of aqueous extract (AE) and saponin fraction QB-90 from Quillaja brasiliensis using poliovirus antigen as model were analyzed and compared to a preparation adjuvanted with Quil-A, a well-known saponin-based commercial adjuvant. Experimental vaccines were prepared with viral antigen plus saline (control), Quil-A (50 µg), AE (400 µg) or QB-90 (50 µg). Sera from inoculated mice were collected at days 0, 28, 42 and 56 post-inoculation of the first dose of vaccine. Serum levels of specific IgG, IgG1 and IgG2a were significantly enhanced by AE, QB-90 and Quil-A compared to control group on day 56. The magnitude of enhancement was statistically equivalent for QB-90 and Quil-A. The cellular response was evaluated through DTH and analysis of IFN-γ and IL-2 mRNA levels using in vitro reestimulated splenocytes. Results indicated that AE and QB-90 were capable of stimulating the generation of Th1 cells against the administered antigen to the same extent as Quil-A. Mucosal immune response was enhanced by the vaccine adjuvanted with QB-90 as demonstrated by increases of specific IgA titers in bile, feces and vaginal washings, yielding comparable or higher titers than Quil-A. The results obtained indicate that saponins from Q. brasiliensis are potent adjuvants of specific cellular and humoral immune responses and represent a viable option to Quil-A.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

SAB3701023 Anti-Mouse IgG (Fc specific)-Peroxidase antibody produced in rabbit, affinity isolated antibody, lyophilized powder
SAB3701037 Anti-Mouse IgG (γ-chain specific)-Peroxidase antibody produced in rabbit, affinity isolated antibody, lyophilized powder
SAB3701165 Anti-Mouse IgG (H+L), F(ab) fragment-Peroxidase antibody produced in rabbit, affinity isolated antibody, lyophilized powder
SAB3701116 Anti-Mouse IgG (H+L)-Peroxidase antibody produced in chicken, affinity isolated antibody, lyophilized powder
SAB3701105
Anti-Mouse IgG (H+L)-Peroxidase antibody produced in donkey, affinity isolated antibody, lyophilized powder
SAB3701083
Anti-Mouse IgG (H+L)-Peroxidase antibody produced in rabbit, affinity isolated antibody, lyophilized powder
SAB3701095
Anti-Mouse IgG (H+L)-Peroxidase antibody produced in sheep, affinity isolated antibody, lyophilized powder
A5906 Anti-Mouse IgG (whole molecule)–Peroxidase antibody produced in sheep, affinity isolated antibody, buffered aqueous solution
A6782 Anti-Mouse IgG (whole molecule)–Peroxidase antibody produced in sheep, affinity isolated antibody, buffered aqueous solution
SAB3701004 Anti-Mouse IgG F(ab′)2, highly cross adsorbed-Peroxidase antibody produced in rabbit, affinity isolated antibody, lyophilized powder
SAB3701003 Anti-Mouse IgG F(ab′)2-Peroxidase antibody produced in rabbit, affinity isolated antibody, lyophilized powder